Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus

Virology

Volumn 413, Issue 2, 2011, Pages 194-204

  Chang, Pey Jium ^a,b   Chen, Lee Wen ^c   Shih, Yan Chung ^a   Tsai, Ping Hsin ^a   Liu, An Chi ^a   Hung, Chien Hui ^a   Liou, Jieh Yuan ^b   Wang, Shie Shan ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

KSHV; Lytic replication; ORF50; ORF50 promoter; YY1

Indexed keywords

BUTYRIC ACID; E1A PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR YY1;

ARTICLE; CELL CLONE; CONTROLLED STUDY; CYTOLYSIS; GENE MUTATION; GENE SILENCING; HUMAN HERPESVIRUS 8; IN VITRO STUDY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; TRANS-ACTIVATORS; VIRUS LATENCY; YY1 TRANSCRIPTION FACTOR;

HUMAN HERPESVIRUS 8;

EID: 79954628592     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.02.013     Document Type: Article

References (37)

1. Atchison L., Ghias A., Wilkinson F., Bonini N., Atchison M.L. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J. 2003, 22:1347-1358.
2. Cai Q., Lan K., Verma S.C., Si H., Lin D., Robertson E.S. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 2006, 80:7965-7975.
3. Cesarman E., Chang Y., Moore P.S., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332:1186-1191.
4. Chang J., Renne R., Dittmer D., Ganem D. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 2000, 266:17-25.
5. Chang P.J., Boonsiri J., Wang S.S., Chen L.Y., Miller G. Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein. Virology 2010, 398:38-48.
6. Chang P.J., Miller G. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J. Virol. 2004, 78:10657-10673.
7. Chang P.J., Shedd D., Gradoville L., Cho M.S., Chen L.W., Chang J., Miller G. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J. Virol. 2002, 76:3168-3178.
8. Chang P.J., Shedd D., Miller G. Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA. J. Virol. 2005, 79:8750-8763.
9. Chang P.J., Shedd D., Miller G. A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance. J. Virol. 2008, 82:9700-9716.
10. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
11. Dalton-Griffin L., Wilson S.J., Kellam P. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions. J. Virol. 2009, 83:7202-7209.
12. Davis D.A., Rinderknecht A.S., Zoeteweij J.P., Aoki Y., Read-Connole E.L., Tosato G., Blauvelt A., Yarchoan R. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001, 97:3244-3250.
13. Gradoville L., Gerlach J., Grogan E., Shedd D., Nikiforow S., Metroka C., Miller G. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 2000, 74:6207-6212.
14. Hyde-DeRuyscher R.P., Jennings E., Shenk T. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res. 1995, 23:4457-4465.
15. Lee J.S., Galvin K.M., See R.H., Eckner R., Livingston D., Moran E., Shi Y. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 1995, 9:1188-1198.
16. Lee J.S., See R.H., Galvin K.M., Wang J., Shi Y. Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Res. 1995, 23:925-931.
17. Liang Y., Ganem D. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl Acad. Sci. USA 2003, 100:8490-8495.
18. Lu F., Day L., Lieberman P.M. Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter. J. Virol. 2005, 79:13180-13185.
19. Lu F., Zhou J., Wiedmer A., Madden K., Yuan Y., Lieberman P.M. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 2003, 77:11425-11435.
20. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V.M., Grossberg S., Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 1997, 71:314-324.
21. Miller G., Rigsby M.O., Heston L., Grogan E., Sun R., Metroka C., Levy J.A., Gao S.J., Chang Y., Moore P. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N. Engl. J. Med. 1996, 334:1292-1297.
22. Montalvo E.A., Cottam M., Hill S., Wang Y.-C.J. YY1 binds to and regulates cis-acting negative element in the Epstein-Barr virus BZLF1 promoter. J. Virol. 1995, 69:4158-4165.
23. Perry R.P. The architecture of mammalian ribosomal protein promoters. BMC Evol. Biol. 2005, 5:15.
24. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad. Sci. USA 1996, 93:14862-14867.
25. Sakakibara S., Ueda K., Chen J., Okuno T., Yamanishi K. Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus orf50/lyta gene expression. J. Virol. 2001, 75:6894-6900.
26. Shi Y., Lee J.S., Galvin K.M. Everything you have ever wanted to know about Yin Yang 1. Biochem. Biophys. Acta 1997, 1332:49-66.
27. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M.F., Clauvel J.P., Raphael M., Degos L., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280.
28. Sun R., Lin S.F., Gradoville L., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl Acad. Sci. USA 1998, 95:10866-10871.
29. Thomas M.J., Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?. Gene 1999, 236:197-208.
30. Wang S.E., Wu F.Y., Chen H., Shamay M., Zheng Q., Hayward G.S. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 2004, 78:4248-4267.
31. Wang S.E., Wu F.Y., Yu Y., Hayward G.S. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J. Virol. 2003, 77:9590-9612.
32. Wang S.S., Chen L.W., Chen L.Y., Tsai H.H., Shih Y.C., Yang C.T., Chang P.J. Transcriptional regulation of the ORF61 and ORF60 genes of Kaposi's sarcoma-associated herpesvirus. Virology 2010, 397:311-321.
33. Wang Y., Li H., Chan M.Y., Zhu F.X., Lukac D.M., Yuan Y. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol. 2004, 78:8615-8629.
34. Wilkinson F.H., Park K., Atchison M.L. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc. Natl Acad. Sci. USA 2006, 103:19296-19301.
35. Wilson S.J., Tsao E.H., Webb B.L., Ye H., Dalton-Griffin L., Tsantoulas C., Gale C.V., Du M.Q., Whitehouse A., Kellam P. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J. Virol. 2007, 81:13578-13586.
36. Ye J., Shedd D., Miller G. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J. Virol. 2005, 79:1397-1408.
37. Zalani S., Coppage A., Holley-Guthrie E., Kenney S. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1. J. Virol. 1997, 71:3268-3274.